Comparative, randomized, open, crossover clinical trial to investigate adhesiveness of a newly developed rotigotine-containing transdermal patch in patients with Parkinson's disease
Latest Information Update: 07 May 2024
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Luye Pharma Group
- 18 Dec 2021 Status changed from recruiting to completed.
- 10 Aug 2021 New trial record